Biological activity of sophorolipids and their possible use as antiviral agents
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
26126789
DOI
10.1007/s12223-015-0413-z
PII: 10.1007/s12223-015-0413-z
Knihovny.cz E-zdroje
- MeSH
- antivirové látky farmakologie terapeutické užití MeSH
- glykolipidy farmakologie terapeutické užití MeSH
- virové nemoci farmakoterapie MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- antivirové látky MeSH
- glykolipidy MeSH
Sophorolipids are surface active glycolipids consisting of a hydrophilic sophorose unit and a hydrophobic portion composed of a fatty acid tail. Crude sophorolipid sample contains both acidic and lactonic forms of sophorolipid with different degrees of acetylation and varying lengths of the fatty acid chains depending on the substrates used in the production process. Carboxylic end in the acidic form of the fatty acid is free, whereas in the lactonic form, it is internally esterified. Sophorolipids show different physicochemical properties with wide range of applications for each structural compound. Lactonic form of sophorolipids shows surface tension reducing ability and biological activity, whereas the acidic form possesses better foam forming ability and higher solubility. Presence of acetyl groups gives hydrophilic nature to the sophorolipids which promotes its antiviral and cytokine-stimulating properties. The aim of this review is to explore and suggest the plausibility of sophorolipids as therapeutic and prophylactic agents for the treatment of viral diseases.
Zobrazit více v PubMed
Colloids Surf B Biointerfaces. 2011 Jul 1;85(2):301-5 PubMed
Biomed Res Int. 2013;2013:512495 PubMed
ScientificWorldJournal. 2014 Jan 14;2014:890709 PubMed
Biochem Res Int. 2013;2013:169797 PubMed
J Surg Res. 2007 Oct;142(2):314-9 PubMed
J Surg Res. 2012 Apr;173(2):286-91 PubMed
FEMS Microbiol Lett. 2010 Oct;311(2):140-6 PubMed
Bioresour Technol. 2010 May;101(9):3170-4 PubMed
Antimicrob Agents Chemother. 2007 Jan;51(1):397-400 PubMed
Appl Microbiol Biotechnol. 2000 May;53(5):495-508 PubMed
Bioconjug Chem. 2006 Nov-Dec;17(6):1523-9 PubMed
Biologicals. 1997 Sep;25(3):289-97 PubMed
Biotechnol Lett. 2006 Feb;28(4):253-60 PubMed
Environ Sci Technol. 2002 Oct 1;36(19):4017-24 PubMed
Appl Microbiol Biotechnol. 2007 Aug;76(1):23-34 PubMed
Antimicrob Agents Chemother. 2005 Oct;49(10):4093-100 PubMed
Ann Clin Lab Sci. 2009 Winter;39(1):60-3 PubMed
J Oleo Sci. 2009;58(11):565-72 PubMed
Appl Microbiol Biotechnol. 1999 Oct;52(4):495-501 PubMed
J Oleo Sci. 2008;57(6):359-69 PubMed
J Surg Res. 2008 Jul;148(1):77-82 PubMed
Antonie Van Leeuwenhoek. 1970;36(1):129-33 PubMed
